JP2014058509A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014058509A5 JP2014058509A5 JP2013169941A JP2013169941A JP2014058509A5 JP 2014058509 A5 JP2014058509 A5 JP 2014058509A5 JP 2013169941 A JP2013169941 A JP 2013169941A JP 2013169941 A JP2013169941 A JP 2013169941A JP 2014058509 A5 JP2014058509 A5 JP 2014058509A5
- Authority
- JP
- Japan
- Prior art keywords
- oral
- pharmaceutical
- active ingredient
- injection
- suppository
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004480 active ingredient Substances 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 229940100691 oral capsule Drugs 0.000 claims 1
- 229940042126 oral powder Drugs 0.000 claims 1
- 239000007935 oral tablet Substances 0.000 claims 1
- 229940096978 oral tablet Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013169941A JP5857008B2 (ja) | 2012-08-20 | 2013-08-19 | C−4”位置換マクロライド誘導体を含有する医薬 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012181339 | 2012-08-20 | ||
JP2012181339 | 2012-08-20 | ||
JP2013169941A JP5857008B2 (ja) | 2012-08-20 | 2013-08-19 | C−4”位置換マクロライド誘導体を含有する医薬 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014058509A JP2014058509A (ja) | 2014-04-03 |
JP2014058509A5 true JP2014058509A5 (enrdf_load_stackoverflow) | 2014-07-17 |
JP5857008B2 JP5857008B2 (ja) | 2016-02-10 |
Family
ID=50615337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013169941A Expired - Fee Related JP5857008B2 (ja) | 2012-08-20 | 2013-08-19 | C−4”位置換マクロライド誘導体を含有する医薬 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5857008B2 (enrdf_load_stackoverflow) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR102810A1 (es) * | 2014-08-18 | 2017-03-29 | Taisho Pharmaceutical Co Ltd | Derivado de macrólido sustituido en la posición c-4 |
CN104592057B (zh) * | 2015-01-12 | 2017-05-10 | 中国科学院上海有机化学研究所 | 一种三硝基乙基氨基甲酸酯的合成方法 |
WO2017142002A1 (ja) * | 2016-02-17 | 2017-08-24 | 大正製薬株式会社 | C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法 |
CN106748905B (zh) * | 2016-12-14 | 2018-04-13 | 河南省化工研究所有限责任公司 | 一种制备2‑氨基乙基磺酰胺盐酸盐的方法 |
CN106928294A (zh) * | 2017-03-22 | 2017-07-07 | 上海启雁实业有限公司 | 制备酮内酯大环内酯类抗生素的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL188173B1 (pl) * | 1996-09-04 | 2004-12-31 | Abbott Lab | Pochodne erytromycyny, sposób wytwarzania pochodnych erytromycyny i środek o działaniu przeciwbakteryjnym |
HN1998000074A (es) * | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
WO2008106204A1 (en) * | 2007-02-28 | 2008-09-04 | Rib-X-Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
AR085286A1 (es) * | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | Derivado de macrolido sustituido en la posicion c-4 |
-
2013
- 2013-08-19 JP JP2013169941A patent/JP5857008B2/ja not_active Expired - Fee Related